Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|October 17, 2024
Core Modifications of GSK3335103 toward Orally Bioavailable αvβ6 Inhibitors with Improved Synthetic TractabilityHeather F Hryczanek, John Barrett, Tim N Barrett, et al.Journal of Medicinal Chemistry|September 10, 2019
Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary FibrosisNiall A Anderson, Sebastien Campos, Sharon Butler, et al.Bioorganic & Medicinal Chemistry Letters|June 23, 2010
Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic painJames W Myatt, Mark P Healy, Gianpaolo S Bravi, et al.Journal of Medicinal Chemistry|September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin InhibitorsPanayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.Journal of Medicinal Chemistry|August 6, 2019
Profile of a Highly Selective Quaternized Pyrrolidine Betaine αvβ6 Integrin Inhibitor-(3S)-3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl)-4-((1S and 1R,3R)-1-methyl-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-ium-1-yl)butanoate Synthesized by Stereoselective MethylationTim N Barrett, Jonathan A Taylor, Daniel Barker, et al.Journal of Medicinal Chemistry|September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αPanayiotis A Procopiou, Niall A Anderson, John Barrett, et al.ACS Medicinal Chemistry Letters|November 20, 2014
Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl SubstituentsJames Adams, Edward C Anderson, Emma E Blackham, et al.ACS Medicinal Chemistry Letters|December 18, 2024
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug DesignRoss P Hryczanek, Andrew S Hackett, Paul Rowland, et al.Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity In VivoChristopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.Journal of Medicinal Chemistry|October 25, 2019
Free-Wilson Analysis of Comprehensive Data on Phosphoinositide-3-kinase (PI3K) Inhibitors Reveals Importance of N-Methylation for PI3Kδ ActivityLydia Barnes, Hollie Blaber, David T K Brooks, et al.Pageof 2